Register now to R3i !
Your Login
Your Password
Confirm Password  
Your Email
The initiative

Prof. Virgil Brown

Prof. Virgil Brown  
Emory Univ. School of Medicine,
Decatur, GA, USA
 
Current position
 
1998 - Chief of  Medicine - Atlanta Veterans’  Affairs Medical Center, Emory University School of Medicine, Atlanta, Georgia, USA
1991 - Charles Howard Candler Professor of Internal Medicine, Emory University, Atlanta, Georgia, USA
 
Past position
 
1987 - 1991 President of the Medlantic Research Foundation, Washington, USA
1978 - 1987 Joseph Lowe and Louis Price Professor of Medicine - Director of the Division of Arteriosclerosis and Metabolism, Mt. Sinai School of Medicine, New York, NY, USA
1970 - 1978 Assistant and Associate Professor of Medicine, Director of the Lipid Research Clinics, University of California San Diego, La Jolla, CA, USA
1966 - 1969 Clinical Associate - National Heart and Lung Institute (NIH), Bethesda, MD, USA
 
Scientific training
 
  Undergraduate degree in physics and chemistry - Emory University (Phi Beta Kappa)
  M.D. - Yale University (Alpha Omega Alpha), CT, USA
  Internal Medicine Residency, Johns Hopkins Hospital, Baltimore, MD, USA
  Fellowship in Endocrinology and Metabolism –Yale, New Haven Hospital, CT, USA
 
Professional Associations
 
1991 -1992 President of the National AHA
1998 Chairman of the Emory University Faculty Council
President of the Senate of Emory University
1998 - 1999 President of the Southeast Lipid Association
2002 - 2004 President of the National Lipid Association
2007 President of the American Board of Clinical Lipidology
President Elect of the International Atherosclerosis Society
 
Awards
 
1985 Humboldt Fellowship to study - University of Cologne, Germany
1987 Distinguished Professor of the Year (The Mt. Sinai Department of Medicine)
1996 “Gold Heart Award”, by the American Heart Association
1999 Master Physician Award, American College of Physicians
2000 Bruce Logue Award, Fulton County Heart Association
 
Research
 
While at the NIH, working with Drs. Donald Fredrickson and Robert Levy, he isolated and characterized for the first time three of the nine proteins involved in the structure of the plasma lipoproteins.  This group of so called “C” apolipoproteins proved to be very important in regulating the levels of the blood triglycerides and cholesterol.

As Director of Lipid Research Clinic at the University of California (San Diego, CA, USA), he continued research on the function of the lipoproteins in carrying cholesterol and triglycerides in the blood.  He and his collaborators helped define the role of the lipase enzymes in breaking down triglycerides so that they could be removed from the blood stream by the various organs of the body.  His studies also helped understand how various dietary changes and medications alter the metabolism of the lipoproteins to correct high levels of cholesterol.  While in San Diego, he was one of the Principal Investigators of the Lipid Research Clinics Primary Prevention Trial which proved that cholesterol reduction prevented first heart attacks in hypercholesterolemic men (1984)